138 related articles for article (PubMed ID: 11475344)
21. Serum leptin, resistin, and lipid levels in patients with end stage renal failure with regard to dialysis modality.
Taskapan MC; Taskapan H; Sahin I; Keskin L; Atmaca H; Ozyalin F
Ren Fail; 2007; 29(2):147-54. PubMed ID: 17365928
[TBL] [Abstract][Full Text] [Related]
22. Association of anion gap with thyroid dysfunction and nodular goiter in CAPD patients.
Lin CC; Yang WC; Ng YY; Chou YH; Tarng DC; Chen TW
Perit Dial Int; 2002; 22(3):394-9. PubMed ID: 12227399
[TBL] [Abstract][Full Text] [Related]
23. Continuous ambulatory peritoneal dialysis (CAPD) adequacy influences serum free carnitine level.
Grzegorzewska AE; Mariak I; Dobrowolska-Zachwieja A
Int Urol Nephrol; 1999; 31(4):533-40. PubMed ID: 10668949
[TBL] [Abstract][Full Text] [Related]
24. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
[TBL] [Abstract][Full Text] [Related]
25. Relationship between the serum parathyroid hormone and magnesium levels in continuous ambulatory peritoneal dialysis (CAPD) patients using low-magnesium peritoneal dialysate.
Cho MS; Lee KS; Lee YK; Ma SK; Ko JH; Kim SW; Kim NH; Choi KC
Korean J Intern Med; 2002 Jun; 17(2):114-21. PubMed ID: 12164088
[TBL] [Abstract][Full Text] [Related]
26. Growth hormone responses to growth hormone-releasing hormone and clonidine before and after erythropoietin therapy in CAPD patients.
Díez J; Iglesias P; Sastre J; Méndez J; Selgas R; Gómez-Pan A
Nephron; 1996; 74(3):548-54. PubMed ID: 8938679
[TBL] [Abstract][Full Text] [Related]
27. Endothelial dysfunction in uremic patients on continuous ambulatory peritoneal dialysis (CAPD).
Rašić S; Hadžović-Džuvo A; Rebić D; Valjevac A; Unčanin S
Bosn J Basic Med Sci; 2011 Aug; 11(3):153-7. PubMed ID: 21875416
[TBL] [Abstract][Full Text] [Related]
28. Impaired glucose tolerance is not associated with lipid intolerance.
Henkel E; Temelkova-Kurktschiev T; Koehler C; Pietzsch J; Leonhardt W; Hanefeld M
Diabetes Nutr Metab; 2002 Apr; 15(2):84-90. PubMed ID: 12059096
[TBL] [Abstract][Full Text] [Related]
29. [The effect of the number of peritonitis episodes on peritoneal membrane function].
Jovanović D; Nesić V; Dimitrijević Z
Srp Arh Celok Lek; 1999; 127(1-2):28-31. PubMed ID: 10377837
[TBL] [Abstract][Full Text] [Related]
30. Leptin in CAPD patients: serum concentrations and peritoneal loss.
Kagan A; Haran N; Leschinsky L; Shuali N; Rapoport J
Nephrol Dial Transplant; 1999 Feb; 14(2):400-5. PubMed ID: 10069196
[TBL] [Abstract][Full Text] [Related]
31. Long-term effect of oral calcitriol single weekly pulse in CAPD and in HD.
Romanini D; Gazo A; Bellazzi R; de Vincenzi A; Nai M; Santagostino M
Adv Perit Dial; 1994; 10():267-9. PubMed ID: 7999842
[TBL] [Abstract][Full Text] [Related]
32. Improvement in sleep apnea during nocturnal peritoneal dialysis is associated with reduced airway congestion and better uremic clearance.
Tang SC; Lam B; Lai AS; Pang CB; Tso WK; Khong PL; Ip MS; Lai KN
Clin J Am Soc Nephrol; 2009 Feb; 4(2):410-8. PubMed ID: 19118118
[TBL] [Abstract][Full Text] [Related]
33. Biochemical parameters, nutritional status and efficiency of dialysis in CAPD and CCPD patients.
Gao H; Lew SQ; Bosch JP
Am J Nephrol; 1999; 19(1):7-12. PubMed ID: 10085443
[TBL] [Abstract][Full Text] [Related]
34. Hypertriglyceridemia is associated with insulin levels in adult cystic fibrosis patients.
Ishimo MC; Belson L; Ziai S; Levy E; Berthiaume Y; Coderre L; Rabasa-Lhoret R
J Cyst Fibros; 2013 May; 12(3):271-6. PubMed ID: 23017500
[TBL] [Abstract][Full Text] [Related]
35. Hyperinsulinism reduction associated with icodextrin treatment in continuous ambulatory peritoneal dialysis patients.
Amici G; Orrasch M; Da Rin G; Bocci C
Adv Perit Dial; 2001; 17():80-3. PubMed ID: 11510303
[TBL] [Abstract][Full Text] [Related]
36. High serum lipoprotein(a) concentrations in uremic patients treated with continuous ambulatory peritoneal dialysis.
Shoji T; Nishizawa Y; Nishitani H; Yamakawa M; Morii H
Clin Nephrol; 1992 Nov; 38(5):271-6. PubMed ID: 1451340
[TBL] [Abstract][Full Text] [Related]
37. Effect of hypertriglyceridemia correction by omega-3 fatty acids on peritoneal transport in continuous ambulatory peritoneal dialysis patients.
Fracasso A; Toffoletto P; Landini S; Morachiello P; Righetto F; Scanferla F; Genchi R; Roncali D; Bazzato G
Perit Dial Int; 1993; 13 Suppl 2():S437-9. PubMed ID: 8399634
[TBL] [Abstract][Full Text] [Related]
38. Clinical performance measures: the changing status of peritoneal dialysis.
Flanigan MJ; Rocco MV; Prowant B; Frederick PR; Frankenfield DL
Kidney Int; 2001 Dec; 60(6):2377-84. PubMed ID: 11737613
[TBL] [Abstract][Full Text] [Related]
39. Serum lipids and lipoproteins during continuous ambulatory peritoneal dialysis.
Lindholm B; Norbeck HE
Acta Med Scand; 1986; 220(2):143-51. PubMed ID: 3776689
[TBL] [Abstract][Full Text] [Related]
40. Comparison of therapeutic efficacy of continuous ambulatory peritoneal dialysis between diabetic and non-diabetic patients: three years of experience.
Tsai TJ; Tsai HF; Wu MS; Chuang CM; Chen WY
Taiwan Yi Xue Hui Za Zhi; 1989 Oct; 88(10):1000-7. PubMed ID: 2699488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
